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ABSTRACT OF THESIS 
SYNTHESIS AND DEVELOPMENT OF ZWITTERIONIC PEI (zPEI) FOR 
OPTIMIZED DELIVERY OF NUCLEIC ACIDS 
Gene therapy holds promise for the treatment a wide range of diseases ranging from 
cystic fibrosis to cardiovascular disease to cancer.  The need for safe and efficient gene 
delivery methods remains the primary barrier to human gene therapy.  Non-viral vector 
materials, including polymers, can be designed to be biocompatible and non-immunogenic, 
but lack the efficiency to be clinically relevant.  Gene therapy awaits the development of 
new materials that are both safe and efficient.  Here, we have synthesized a series of 
modified zwitterionic polymers based on the common transfecting agent polyethylenimine 
(PEI).  Using a variety of biochemical and biophysical methods we have studied structure-
function relation in zPEI-DNA as a function of percent modification.  Our results show 
significant structural rearrangements in the DNA condensates with increasing zwitterionic 
character.  The percent zwitterionic modification determines not only DNA packaging but 
the serum stability of the resulting polyplexes with more highly modified zPEI releasing 
DNA more readily.   
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Chapter 1: Introduction 
1.1. Introduction to Gene Delivery by Chemical Transfectors 
Many human diseases result from mutations in genetic material that lead to poor 
regulation of gene expression or transcription and translation of flawed proteins.  For 
example, cancer is caused by mutations in oncogenes, which leads to unregulated cellular 
proliferation1.  Cystic fibrosis results from an inherited mutation to the gene encoding 
CFTR, a chlorine ion channel, which leads to mucus buildup affecting lung function2.  
Other than treatment of symptoms, increasing understandings of the genetic origins of 
disease has promoted efforts to modulate expression or introduce non-pathogenic copies 
of genes3.  Additionally, introduction of genetic materials into cell cultures and animal 
models has become invaluable to the study of protein function as well as study of disease 
and therapeutics4.  While the gene therapy field once showed great potential, the small 
number of clinical trials and lack of pharmaceutical application has resulted from 
inadequacies in current delivery techniques.5-6  In order to be effective in treatment, a gene 
carrier must be nontoxic, must protect the gene from extracellular and intracellular 
degradation, must be able to deliver the gene into the cells of interest, and must release its 
cargo into the nucleus or cytoplasm so that it can be transcribed.5, 7   
Existing transfection techniques can be grouped into two categories: viral and non-
viral.  Because viruses have been subject to natural selection, they have evolved with 
characteristics to overcome the major obstacles of transporting DNA into a host cell.5  
While viral based vectors sport very high transfection efficiencies, their widespread use is 
limited due to a variety of factors.  Both adenovirus and retrovirus derived vectors suffer 
from risk of contamination with an active “helper” virus, and limitations in size of DNA 
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payload.8-9  Adenoviral vectors currently are limited in efficiency, partially due to being 
limited by the cell host’s life cycle.8  Retrovirus derived vectors suffer from risk of 
immunogenic response, of accidental infection with a self-replicating virus, and of faulty 
replication of the gene of interest by reverse transcriptase.9  Such an error could result in 
higher expression of a faulty gene, worsening or accelerating the targeted disease.  These 
concerns have been amplified by the death of early participants in clinical trials, such as 
Jesse Gelsinger, who died in 1999 as a result of viral injection in an attempt to cure his 
ornithine transcarbamylase deficiency (OTC), setting viral delivery research back as a 
result of the public backlash.	 10  Physical methods such as microinjections or 
electroporation show limitations in efficacy due to potential for cellular damage.7  In 
addition, they are often low throughput, and difficult to apply to organisms of high cellular 
diversity.7  While current chemical agents show lower efficiencies than viral vectors, their 
reduced risk of immunogenicity along with large variability in chemical structure and ease 
of production give them high potential as gene carriers.5, 7   
Cationic polymers, such as polyethylenimine (PEI) and polyamidoamide 
(PAMAM), along with peptides and lipid carriers, are among the most well studied 
chemical transfection agents.7  A commonality between the major chemical transfectors is 
the ability to interact with and bind to DNA through electrostatic interaction with the 
negative phosphate backbone.4-5, 11    While lipid carriers, such as lipofectamine, are well 
established transfection agents for laboratory cell work, poor performance in vivo, as well 
as difficulty of consistent sample preparations limit their application in a clinical setting.5,
11 Cationic polymers, such as polyethylenimine (PEI) and polyamidoamine (PAMAM), 
suffer from high cellular toxicity and low transfection efficiency when compared with viral 
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vectors, but their use carries a much lower risk of infection or of an immune response.5  
Because their chemical structures and properties are readily tunable, a great potential exists 
for optimization of commercially available cationic polymers for transfection.5  While it is 
clear that a relationship exists between the structure of chemical agents and their ability to 
deliver DNA for expression, the field still lacks rigorous characterization of the parameters 
that lead to transfection.  Previous research has shown improved transfection efficiency 
and cytotoxicity in polyplexes, polycation-DNA complexes, by reducing nonspecific 
interactions with proteins, blood and other biological components; in addition to loosening 
the strength of the interaction between the polymer and the nucleic acid payload, to 
facilitate more efficient cellular release.12-25  This has been accomplished through addition 
of charge neutral hydrophilic groups such as PEG by grafting, use of negatively charged 
copolymers, reduction of charge by covalent modification, and through addition of 
hydrolysable charge shifting groups.12-25  A better understanding of how such alterations 
modulate the properties of interaction between chemical agents and their nucleic acid 
payload is needed for continued progress in creating improved molecules for gene delivery.  
Previous work by the DeRouchey group has shown, surprisingly, that mixed charge 
peptides are capable of condensing DNA.  The resulting DNA packaging is influenced by 
both the number and chemical nature of the negative moiety.  In this thesis, we have 
modified a commercial 25 kDa branched polyethyleneimine (bPEI) polymer through 
reaction with succinic anhydride to form mixed charge, or zwitterionic, PEI (zPEI).  By 
modulating the ratio of PEI to succinic anhydride, a series of zPEI were synthesized with 
varying degrees of modification through reaction of succinic anhydride with primary and 
secondary amines on bPEI.  With a combination of structural studies in addition to cell 
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work performed by collaborators in the laboratory of Dr. Dan Pack (University of 
Kentucky, Chemical and Materials Engineering), we have explored how the percent 
modification of zPEI affects the binding, protection, and release properties, as well as the 
packaging density of the resulting polyplexes.  Our hypothesis is that zwitterionic PEI will 
provide the ability to systematically tune polymer-DNA interactions leading to polyplexes 
with enhanced intracellular unpackaging and more efficient gene delivery.  At high percent 
modification, we anticipate the polymer-DNA interactions are too weak for effective DNA 
delivery, thus an optimal ratio of modification should be determined for zPEI.  Generally, 
for nonviral delivery of polymers, a large excess of polycation (typically amine based) must 
be used to form stable colloidal nanoparticles suitable for DNA delivery. As these 
polycations are generally toxic to cells, we also hypothesize zPEI will result in polymer 
carriers with reduced cellular toxicity. This chapter will broadly review existing literature 
on polycationic transfection agents.  The following chapters will detail the synthesis and 
characterization of the zwitterionic PEI (zPEI) along with biophysical characterization 
(chapter 2) and x-ray studies on DNA polyplex formation (chapter 3).   
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1.2.  Structure of Polymer Based Transfection Agents 
 
The structures of several common variants of chemical transfectors are shown in 
figure 1.1.  This work focuses on the cationic polymer transfectors, which will be discussed 
in greater detail. Polylysine, one of the first cationic polymers proposed to be used for 
delivery of genetic material, is simply a chain of the amino acid lysine conjoined by peptide 
bonds between the a-amino and a-carboxylic group of adjacent lysine residues.26  The net 
positive charge of the polymer results from the lysyl group containing a primary amine.   
Polyethylenimine (PEI), one of the most well established chemical transfection 
agents, is made up of repeating ethylendiamine units.  PEI exhibits high transfection 
efficiency compared to many other polymers and is often considered as a “gold standard” 
in gene delivery.  Commercially available PEI is often characterized in two ways; by the 
average molecular weight of individual polymer chains, and by the presence or absence of 
branching in the molecule.27  As pictured in figure 1.1, PEI can be either linear (lPEI) or 
branched (bPEI).  The amine groups lend a high positive charge to the molecules at 
physiological pH.  The branched form of PEI (bPEI) contains a combination of primary, 
secondary, and tertiary amines, and the linear form predominantly contains secondary 
amines.   PEI used throughout this work, 25 kDa bPEI, has been shown by C13 NMR 
analysis to contain roughly 31% primary, 39% secondary, and 30% tertiary amines.28  bPEI 
is thought to be especially effective due to the presence of these secondary and tertiary 
amines, which provide buffering capability over a wide range of pH.29  Acid titration 
studies of branched PEI reveal broad pKa distributions.29  Because PEIs are made up of 
neighboring amine groups, both the covalent linkage and the close proximity of adjacent 
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branches alters the pKa of neighboring amines.22, 29  A simplistic example can be seen for 
a single ethylenediamine, a symmetric molecule made up of an ethyl group with single 
primary amines attached to each carbon.  However, these two, seemingly identical, 
nitrogen have different pKas (9.98 and 7.52).29  As the first amine protonates below pH 
9.98, the pKa of the unprotonated nitrogen decreases due to the proximity to the charged 
amine.  Because of the random branching structure and large number of amines per 
molecule of PEI, the individual pKas and orders of protonation/deprotonation are not well 
established, but mathematical fits of titration data on 500 kDa branched PEI estimate that 
at a physiological pH, roughly 80-90% of nitrogen are uncharged.29  Another group, who 
studied a 10 kDa variant of bPEI, reported that 70% of nitrogens remained uncharged at 
pH 7.4.30 The wide range of pKas of PEI nitrogen make the molecules good physiological 
buffers.   
Polyamidoamine (PAMAM), another commercially available cationic transfection 
agent, differs from both branched and linear PEI in that it is a dendrimer.5, 31  Dendrimers 
are named for their branched, “tree like” structure, and are made up of repeating, radial 
symmetric branched units around a central “core” molecule.31-32  Because of their high 
degree of symmetry, and tight control over parameters, such as surface chemistry and 
number of surface groups, dendrimers represent a potential alternative to linear and 
disordered branch structures for use in DNA polyplex assembly and delivery.   Higher 
generation PAMAM dendrimers are thought to be spherical in form and terminate with an 
outer layer of primary amine groups.31  PAMAM dendrimers are typically synthesized by 
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a divert method through a repeating two-step reaction process, a Michael addition followed 
by amidation, that results in two new branches off of every primary surface amine. 31-32  
Every cycle of these reactions is referred to as a new generation, where the number of 
reactive surface groups is double the previous generation.31   For example, if the reaction 
is terminated after the first cycle on an ethylenediamine (bifunctional) core, the resulting 
polymer will be termed PAMAM G0, for generation 0 and have 4 primary amines on its 
surface.  If the Michael addition/amidation cycle is repeated 4 times, the product will be 
third generation PAMAM (G3 PAMAM) and have 32 primary amine surface groups.  
PAMAM G1 is presented in figure 1.1. G4 PAMAM was used in this study with 64 surface 
amine groups.  Titration experiments have shown that the outer primary amines of G4 have 
pKas of 9.9, thus possessing charge at physiological pH.33  The effective charge of G4 
PAMAM however is expected to be less than +64.  Tertiary amines have pKas of ~6.5, and 
non-surface group amines of PAMAM are thus believed to be uncharged at physiological 
pH.  At low pH, such as that found in lysosomes, these tertiary amines may be charged. 33-
34   Like PEI, PAMAM dendrimers are good physiological buffers.34  
 
 
1.3. Mechanism of DNA Binding and Delivery 
  
Efficient delivery of nucleic acids for non-viral gene therapies must include means 
to successfully navigate several kinetic and energetic barriers; including effective 
compaction and particle stability of the polyplexes to be efficiently internalized by cells 
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yet sufficiently labile to subsequently release the nucleic acids for delivery.5  A simple 
cartoon depicting the barriers to cell transfection is displayed below in figure 1.2.  
The first barrier a chemical transfector must navigate is transportation and 
protection of the nucleic acids through a tightly regulated and degradative extracellular 
environment.  Naked nucleic acids are not capable of effectively crossing the cell 
membrane due to their large size and charge.  To overcome this barrier, various condensing 
agents have been successfully used to create nanometer sized complexes capable of more 
readily carrying nucleic acids across the cell membrane.35  Additionally, degradative 
enzymes, such as DNAse, which are present extracellularly and intracellularly, severely 
limit the time that cell targets are exposed to unprotected genes.36-37  Condensing agents, 
such as PEI, also prevent DNA degradation in cells for several hours.5, 36   DNA particles 
bind to polycations spontaneously in dilute aqueous solutions forming nanometer scale 
particles called polyplexes.4-5, 11, 38-39  Interactions between DNA and polymer are the result 
of electrostatic forces between the negative DNA backbone and the positively charged 
groups on the polymer.7  It is believed that this process is made entropically favorable by 
the release of counter-ions from the oppositely charged molecules into solution.40-41  
Polyplexes are often found to have the highest transfection efficiencies when the number 











Figure 1.2.  Cellular barriers for effective chemical transfection 
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DNA.42  Experimentally, this is represented as a molar ratio of nitrogen to DNA phosphate, 
or N/P charge ratio.  Excess polycation (i.e high N/P ratios) is required for the formation 
of sufficiently small, stable nanoparticles for efficient cellular uptake. 43-45  The small size 
of these particles also allows for more efficient diffusion through intracellular and 
extracellular fluid.   
The positively charged polyplexes are able to associate with the negative head 
groups of cellular membrane lipids, which helps to facilitate endocytosis.42  Polyplexes are 
believed to enter the cells through three different endocytotic pathways: Clatherin-
dependent endocytosis, the Caveolae pathway, and pinocytosis.46  Once taken up into the 
cell through endosomes, polyplexes must be transported towards the nucleus.  Fluorescence 
studies by Suh, et. Al. suggest that endosomes containing cationic polyplexes likely traffic 
near the nucleus by active transport along microtubules.47   
The high positive charge density of the polymers contributes to the high buffer 
capacity, which is believed to be integral to polyplex release from endosomes for PEI and 
other cationic transfectors.29, 48 Both Clatherin-dependent endocytosis and pinocytosis 
result in lysosomal degradation of endosomal contents.46  The lysosomal pathway utilizes 
low pH along with degradative enzymes to break foreign materials along with recyclable 
cell components into their base biological molecules for use by the cell.49  Additionally, 
one study by Gabrielson and Pack indicates that acidification also occurs in Caveolae 
derived endosomes, even though such vesicles are not destined for lysosomal 
degredation.50  The mechanism by which cationic polyplexes are released from endosomes 
into the cytoplasm is still highly debated, but the most well accepted idea in the literature 
is known as the “proton-sponge hypothesis”.  According to this hypothesis, originally 
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proposed by Behr, the broad buffer capacity of PEI and PAMAM polyplexes resists 
acidification by proton pumps in endosomes.5, 48  In response, proton pumps release more 
H+ ions into the vesicles, leading to larger influx of counter-ions.5  Osmotic swelling 
accompanies the increase in ion concentration, resulting in membrane rupture and release 
of polyplexes.5, 51  Inhibition of endosomal acidification by drugs such as Bafilomycin and  
Nigericin lead to significant reductions in transfection efficiency, lending credibility to this 
idea.34, 46  Additionally, microscopy studies have visualized endosomal burst in cells 
exposed to polycation/DNA complexes.52  
 While this mechanism has come to be accepted by many in the literature, a handful 
of studies call into question the validity of the “proton-sponge hypothesis”.  Banjaminsen 
et. al. used pH sensor nanoparticles co-localized to the lysosomes with fluorescently tagged 
PEI polyplexes to show that the pH of endosomes did not significantly change with the 
addition of PEI as would be expected if the concentration of PEI was high enough to cause 
endosomal burst by buffering.53 Additionally, estimates of osmotic stress induced by 
polycation complexes by this buffering effect do not seem to indicate that endosomal burst 
is a realistic outcome.51, 53  For this reason, it was suggested by Benjaminsen et al.  that 
micron sized pore formation, as reported to be induced by surfactants in liposomes, may 
be another possible mechanism of endocytotic escape.53-54  The presence of such pores in 
PEI transfections was observed by laser scanning microscopy by Bieber et. al. and have 
been proposed to be a source of the toxicity observed.55-56 
Once DNA cargo have reached the cytoplasm, they must be transported through the 
nuclear membrane.  The mechanisms underlying this process are very poorly characterized, 
and consensus on the pathway that polyplexes take is still to be reached.  It is unclear 
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whether or not polyplexes travel through the nuclear membrane intact, or whether DNA 
must be released from polymer before transportation.  The nuclear membrane is only wide 
enough for particles 30 nm or smaller to translocate through, which would preclude many 
cationic polyplexes based upon size alone.57-58   A two colored Fluorescence correlation 
spectroscopy (FCS) study by Clamme et. al. did not indicate that bound polycation/DNA 
complexes existed within the nucleus during transfection, but did show that free polymer 
was present inside of the nucleus during transfection.59  Both Clamme et. al. and Suh et. al. 
observed accumulation of PEI/DNA complexes was observed in the cytoplasm around the 
nucleus.47, 59  Additionally, it has been suggested that transfection efficiency may be 
dependent upon cell cycle, with efficiency increasing during mitosis, when the nuclear 
membrane breaks down.60  In fact, transfection studies of polymer and lipid transfections 
show higher efficiency in actively dividing cell cultures.61-62  Alternatively, efforts have 
been made to add nuclear localization signals to genes of interest to increase nuclear uptake 
in non-dividing cell cultures, which are of interest for clinical applications.60  
Whether it be intranuclear or perinuclear, several mechanisms for DNA release 
from polymer have been proposed.  DNA release could be mediated by competitive binding 
of the cationic polymer with nucleic acids, most likely RNA, or  other negative cell 
components.63-64   Additionally, if the polyplex exists in the nucleus, Thomas and Klibanov 
have suggested that DNA could be stripped away from the polymer by the DNA 
polymerase complex, as has been observed to occur with histone bound DNA.7, 65  
Regardless of the mechanism of endosomal escape, cell transport, and nuclear 
translocation, it is clear that very few of the DNA molecules transfected end up in the 
nucleus, and the majority are degraded in the cytoplasm.60   
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While the positive charge of cationic DNA polyplexes confers characteristics that 
enhance transfection, it also comes with several drawbacks.  Polyplexes can bind to cell 
structures, such as proteins and membranes, which can lead to cell death.66-67  Additionally, 
in vivo, the positively charged polyplexes can bind to blood cells and negatively charged 
blood proteins, which lowers the efficiency of delivery.17, 68-69  One study by Hong et. al.  
has shown that the high positive charge of polyplexes can lead to increases in permeability 
of membranes through pore formation, which in excess is deleterious for cells.56   
A large number of factors, at times competing with one another, govern the 
effectiveness of cationic transfectors.  An effective chemical agent must be capable of 
binding and condensation of DNA cargo, protection of payload from enzymatic 
degradation, and mediation of transport through the extracellular space into the cytoplasm 
and nucleus of the cell.  However, the nucleic acids must not be so tightly bound that they 
are unable to be released and transcribed by the target cell, nor should the polyplex be 
harmful to cells or tissues.   Development of better chemical transfectors, therefore, 
necessitates careful consideration of these factors that influence polymer/nucleic acid 
interactions.   
1.4. Attempts to Optimize Gene Delivery 
Because the commonly utilized commercial polymers, such as PEI and PAMAM, 
were not made to address the diverse barriers associated with gene delivery, great potential 
exists to modulate their chemical properties in order to better optimize ability to transfect.  
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As discussed above, successful gene delivery requires overcoming various energetic 
barriers.  Often these barriers are in direct competition and therefore an optimization of 
these barriers is required.  Because a high net positive charge is a common trait in chemical 
transfectors, many groups have studied the effects of charge reduction or modulation upon 
the efficiency of transfection.  As described in the previous section, a high nitrogen to 
phosphate (N/P) ratio is necessary to condense polyplexes into stable nanoscale particles, 
and is important for endosomal escape into the cytoplasm, but can also be deleterious to 
cells and cause nonspecific interactions with components of blood and other tissues.  
Through reduction of the overall positive charge of the polymer, the affinity of DNA 
release may be modulated, as well as the extent of binding to negatively charged cellular 
components or blood/serum proteins.  If an optimal charge density can be established, the 
limits of transfection efficiency and cytotoxicity of the base polymer may be improved in 
vitro and in vivo.  There are several modes by which various groups have accomplished 
this goal.  By grafting biocompatible and neutral groups such as polyethylene glycol (PEG) 
or dextran carbohydrate chains to PEI, several groups have noted a reduction in 
cytotoxicity and an increase in transfection efficiency over the base polymer.16-19  
Additionally, creation of tertiary complexes, by addition of an anion to polyplexes after 
complexation is believed to reduce cytotoxicity and nonspecific binding to proteins by 
reducing the positive charge on the outside of polyplexes, and through binding up free 
polycation in solution following preparation.12-15  In addition to these two means of charge 
modulation, many groups have sought to reduce charge through covalent reaction of the 
positive amine groups.  Acetylated branched PEI through creation of an amide bond on the 
primary and secondary amines was shown to decrease the binding affinity for DNA, 
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increase the intracellular release, and overall increase transfection efficiency up until a 
critical percent modification.21-22  Other groups have shown PEI with covalently attached 
neutral zwitterions such as 2-methacryloyloxyethyl phosphorylcholine (PMPC) is both less 
cytotoxic and a more potent transfector than unmodifiedPEI, which is very similar to what 
was observed in PEG grafting onto PEI.23-24  Additionally, work has been done by Lynn 
et. al. to create “charge-shifting” PEI derivatives that, when hydrolyzed over time, lead to 
an increase in negative charge along the polymer.25  This approach has shown that a time 
based zwitterionic modulation of PEI can also lead to increases in transfection efficiency.  
The success of modification studies such as these indicate the potential for fine tuning the 
transfectibility of chemical agents by modulation of their positive charge, and suggest that 
further optimizations may lead to more viable chemical agents that are better able to 













Chapter 2: Synthesis and Characterization of Zwitterionic PEI 
2.1. Introduction 
While the high cationic charge of PEI lends itself towards high cytotoxicity and 
low serum stability; it also allows for the condensation, tight packaging, and endosomal 
escape necessary for gene expression.5, 36, 55-56, 66-69 Not only must DNA be tightly packaged 
and protected from enzymatic degradation, but also must be released at an appropriate 
cellular location.5, 7, 36-37  For this reason, a balance in the charge content of PEI through 
addition of zwitterionic character could lead to optimal transfection.  Previous work by the 
DeRouchey group indicated that mixed charge peptides were able to condense DNA.  Here, 
zwitterionic charge was introduced to 25 kDa branched polyethylenimine (bPEI) through 
addition of succinyl groups through post polymerization modification.  In collaboration 
with the laboratory of Dr. Pack, a spectrum of succinylated PEI derivatives (zPEI) were 
created.  This chapter will explore the relationship between percent modification of zPEI 
and the resulting binding and release properties of DNA with the polymer.   
2.2. Materials and Methods 
2.2.1. Materials 
Branched 25 kDa PEI, succinic anhydride, hydrochloric acid (37%), solid sodium 
hydroxide, dextran sulfate, D2O, and sodium azide were purchased from Sigma Aldrich 
(St. Louis, MO).  Sodium Carbonate, 10 x phosphate buffered saline, ethidium bromide, 
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30% glycerol, 2k MWCO Slide-A-Lyzer dialysis cassettes, and 0.5 M EDTA were 
purchased from ThermoFisher Scientific (Waltham, MA).  Sodium Bicarbonate was 
purchased from EM Science (Darmstadt, Germany).  Tris-Acetate-EDTA buffer (TAE, 
50x) was purchased from Omega Bio-tek (Norcross, GA).  Tris HCL buffer was purchased 
from Madiatech, Inc (Manassas, VA).  Plasmids pUC19 (1 mg/mL) and pUC18 (0.5 
mg/mL) were purchased from New England Biolabs (Ipswich, MA) and ThermoFisher 
Scientific (Waltham, MA) respectively.  DNA ladder (1 kB) was purchased from 
Fermentas Biotechnology (Waltham, MA).  Solid Agarose I, 0.2 micron syringe filter units, 
and 1000 mL 0.2 micron PES vacuum filter units were purchased from VWR (Radnor, 
PA).  Bromophenol Blue was purchased from Eastman Kodak (Rodchester, NY).  All 
double distilled H2O used was purified through a dH20 – Milli-Q water purification system 
equipped with a 0.22 micron Millipak 40 sterile Millipore filter (Billerica, MA).  
Acetylated PEI received from Logan Warriner (UK Chemical and Materials Engineering, 
Laboratory of Dr. Dan Pack).   
2.2.2. Synthesis and Characterization of zPEI 
2.2.2.1 Synthesis and Purification of Succinylated PEI 
Sodium bicarbonate buffer (0.1 M, pH 9) was prepared by mixing aqueous 
solutions of 0.1 M sodium carbonate and 0.1 M sodium bicarbonate.  A half gram of 25 
kDa branched PEI was dissolved in 3 mL of pH 9 bicarbonate buffer in a 7 mL scintillation 
vial.  Once dissolved, solid stock of succinic anhydride was added and immediately mixed.  
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The amount of succinic anhydride was chosen based upon the intended molar ratio of 
substitution.  Samples were magnet stirred and allowed to incubate at 60 °C for 4 hours.  
Following reaction, solutions were filtered through a 0.2 micron syringe filter.  The 
resulting solutions were loaded into 2K MWCO Slide-A-Lyzer dialysis cassettes and 
allowed to equilibrate with double distilled water (ddH2O) for 48 hours with constant 
replacement of the external water solution.  After 48 hours, the solutions were emptied 
from the dialysis cassettes and frozen at -80 °C prior to lyophilization.  Synthesis was 
performed by Logan Warriner (Chemical and Materials Engineering, University of 
Kentucky) and Joseph Duke (Chemistry, University of Kentucky).   
 
 
2.2.2.2. H-NMR and FTIR Analysis 
  
 In order to evaluate the yield of the reaction and test for the presence of unwanted 
side reactions, H1-NMR and FTIR spectra were taken on the succinylated PEI in addition 
to the unmodified branched PEI.  For H-NMR, samples were dissolved at ~5-10 mg/mL in 
dH2O.  Percent succinylation was estimated by Logan Warriner from H-NMR spectra 
taken on a 400 mHz Varian NMR spectrometer.  NMR data processed and integrated using 
Agilent VnmrJ software.  An iS50 FT-IR equipt with a diamond ATR was used to collect 
absorbance data from 4000-400 cm-1 radiation from spectrum on solid PEI stocks through 
OMNIC software (ThermoFisher Scientific; Waltham, MA).  FTIR data was output as a 
CSV file for processing in Origin (OriginLab Corporation; Northampton, MA).  
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2.2.2.3. pH Titration 
For each of the zPEI derivatives and the unmodified, 2 mg were dissolved into 5 
mL of ddH2O.  The pH of each sample was adjusted to 11.5 using 1 M sodium hydroxide.  
Each solution was then titrated with 5 µL additions of 1 M HCl.  Solutions were mixed 
well prior to pH measurement on an Accumet AB15 pH meter (Hudson, MA).  Titrations 
were performed by Logan Warriner and Joseph Duke.   
2.2.3. Characterization of DNA Polyplex Formation 
2.2.3.1. Gel Retardation Assay 
Agarose gel electrophoresis was utilized in order to assess DNA condensation 
efficiency of unmodified and modified (uPEI and zPEI, respectively).  200 ng of plasmid 
DNA (pUC19 or pUC18) were mixed with the desired weight ratios of PEI.  Both DNA 
and plasmid was prepared in 10 mM Tris (pH 7.5), 400 µM NaN3 buffer that was filtered 
before use with a 0.2 µm PES filter unit.  All samples were brought up to a final volume 
of 12 µL by addition of Tris buffer, vortexed for ~1 minute, and allowed to incubate at 
room temperature for 45 minutes before loading the sample onto the gel. Following 
incubation, 2.4 µL of 6x loading dye was added to each sample and mixed.  Ten µL of each 
PEI/DNA sample was pipetted into the wells of a 0.8% agarose gel and ran at 100 V for 
approximately 2 hours in 1xTAE buffer (40 mM Tris pH 8, 20 mM acetic acid, 1 mM 
EDTA, made from dilution of 50 x stock into ddH20, passed through a 0.2 µm PES filter.  
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Samples were run next to a single well of 20 µg/mL solution of 10 kbase DNA ladder 
dissolved in 10mM tris.  All agarose gels were prepared by dissolving agarose in 1x TAE 
buffer by microwave heating, and allowing to cool for at least 1 hour.  Gels were stained 
for 45 minutes in a 200 µL solution of 0.5 µg/mL ethidium bromide dissolved in 1xTAE.  
Gels were subsequently destained for 30 minutes in 200 µL 1xTAE solution.  A BioRad 
ChemiDoc MP Imaging System was used to image each gel through Image Lab software 
(BioRad; Hercules, Ca).   
 
 
2.2.3.2. Polyplex stability in the presence of Dextran sulfate 
 
In order to determine the stability of DNA/zPEI complexes, polyplexes of 
PEI/pDNA (0.2 ug pUC19) at fixed w/w ratio, chosen based upon the needs of the 
experiment as discussed below, were brought to a final volume of 5 µL in 10 mM tris buffer 
and incubated for 45 minutes at room temperature.  The desired weight ratio of a competitor 
polyanion, here dextran sulfate (DS) in 10 mM Tris, was then added to the samples to 
induce DNA release.  All DS/PEI/pDNA samples were then brought to a final solution 
volume of 12 µL by addition of 10 mM Tris.  Samples were then vortexed and incubated 
for 30 minutes.  2.4 µL of 6x loading buffer and preparing and running 0.8% agarose gel 
as described above.   A BioRad ChemiDoc MP Imaging System was used to image each 




2.2.3.3. DLS Zeta Potential Characterization 
Polyplex solutions were formed by preparing a 0.02 mg/mL solution of pBR3 
plasmid in 0.1 x PBS.  Polymer solutions dissolved in 0.1xPBS at appropriate 
concentrations for the desired weight ratio of polymer to plasmid were added dropwise to 
the DNA solution while being mixed.  Samples were well mixed and left to incubate at 
room temperature for 30 minutes.  Polyplex solutions were diluted to 1 µg/mL in 0.1xPBS 
prior to measurement.  A Zetasizer Nano ZS (Malvern Instruments; Malvern, UK) was 
used to collect all DLS and Zeta potential measurements.  All DLS and Zeta Potential 
measurements and sample preperations performed by Logan Warriner.   
2.3. Results and Discussion 
2.3.1. Characterization of Synthetic Product 
2.3.1.1. Spectroscopic Analysis of zPEI 
In order to probe the effect of increased zwitterionic character upon the ability of the 
commercial transfecting agent polyethylenimine (bPEI) to condense DNA, a series of 
zwitterionic PEI derivatives (zPEI) were synthesized through post-polymerization 
modification via succinylation of primary and secondary amines as depicted in Figure 2.1. 
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zPEI with percent modification ranging from 5-35% were synthesized by reaction of 
commercially available, 25kDa branched PEI dissolved in 0.1M bicarbonate buffer (pH 9) 
with succinic anhydride.  Branched PEI is contains a mix of primary/secondary/tertiary 
amines, broadly thought to have a ratio of 25/50/25.28  The variant used in this work, 25 
kDa bPEI, has been reported by Sigma Aldrich to contain an amine content of roughly 31% 
primary, 39% secondary, and 30% tertiary amines. By varying the SA:PEI ratio in the 
reaction mixture, polymers with varying degrees of modification are obtained through 
reaction with primary and secondary amines.  By adjusting the pH to 9 with bicarbonate 
buffer, we expected to improve yield of succinylation by deprotonating the PEI amines 
increasing the nucleophilicity of the amine nitrogen.  bPEI and succinic anhydride were 
mixed and allowed to react for 4 hours. Following the succinylation, zPEI samples were 
dialysized to remove residual succinic anhydride and freeze-dried.  	
Total percent of amines reacted was characterized via H1-NMR by Logan Warriner 
by division of the integration of peaks representing the succinyl methylene at d 2.3-2.5 by 
those representing the PEI ethylene backbone at d 2.6-3.34.  H1-NMR characterization 
+
Figure 2.1. Reaction scheme for the synthesis of succinylated PEI (zPEI) using 
succinic anhydride.  Reaction is also possible with secondary amines, but for 
simplicity, only substitution upon primary amines are shown.   
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revealed percent substitutions of 5.8, 8.0, 15.4, 26.7, and 35.0% of total amines reacted for 
the 5 different PEI derivatives reacted and purified.  A previous paper focused on siRNA 
delivery by Zintchenko et al. performed succinylation of PEI but saw a maximum of 20% 
amine groups reacted when the reaction was performed in pH 5 solution of water and 
DMSO.20 siRNA knockdown was then examined but only at the one percent 
modification.20 
In order to ensure that the succinylation of bPEI was the primary product, FTIR was 
used to characterize the functional groups of our post-polymerization succinylation.  
Because different bond types have bending and stretching modes with frequencies on the 
order of infrared (IR) radiation, IR absorption spectra of a sample can be used to identify 
functional groups of interest.70  Of concern was the potential for unintended side reactions, 
namely crosslinking or ring closure to form a succinimide group (figure 2.2).  Both 
formation of succinimides and crosslinking, either via intra- or inter-molecular nitrogen, 
would reduce the overall charge at neutral pH by replacement of amine groups with amide 
groups with reduced pKa values, in contrast to the production of zwitterionic character that 
was intended.  Inter-molecular crosslinking would lead to larger molecular weight 
branched PEI derivatives, which would also confound the effects of charge modulation. 
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The resulting IR absorbance spectrum of our 5 zwitterionic derivatives of branched 
PEI, along with the unmodified, are depicted in figure 2.3 below.  In unmodified PEI, two 
peaks at ~2934 cm-1 and ~2815 cm-1 indicate the presence of C-H stretches corresponding 
to the ethyl groups present in PEI.  The peaks at ~3349 cm-1 and ~3270 cm-1 indicate the 
N-H stretch of primary and secondary amines.  As the percent modification increases, the 
first of these peaks is diminished in intensity, indicating the disappearance of primary 
amines.  The two peaks at 1592 cm-1 and 1456 cm-1 correspond to the N-H and C-H bends 
in the amine and ethyl groups respectively.  As percent succinylation increases, bands 
appear at 1629 cm-1 and 1548 cm-1 indicating the presence of a C=O stretch in the amide 
bonds and carboxylate groups created, and at 1393 cm-1 indicating C-O stretches in the 
carboxylate of the succinyl group added.  A broad peak appears between 3500 and 3000 
cm-1, which is likely due to the presence of an O-H bend on the succinyl group COOH, but 
could also represent hydrogen bonding between succinyl groups and PEI amines.  A sharp 
Figure 2.3.  FTIR Analysis of Succinylated bPEI Derivatives 
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peak at ~1750 cm-1 indicating the C=O stretch of a succinimide group was not detected in 
any of the spectra taken, which is evidence against succinimide formation as a side 
reaction.   It is difficult to say whether or not crosslinking is evident from the spectroscopic 
analysis performed, but high molecular weight inter-molecularly crosslinked products are 
likely to be largely eliminated by the filtration of products following synthesis. During 
synthesis, insoluble precipitation was observed, likely high molecular weight crosslinked 
PEI, but filtration through a 0.2 micron pore size was used to remove precipitants prior to 
dialysis and lyophilization.  Zeta potential and gel electrophoretic data later discussed in 
sections 2.2.2 indicate the presence of negative charge in addition to the reduction of 
positive charge, likely meaning that if side reactions were present, they did not entirely 
remove the added negative charge of the succinyl groups.   
2.3.1.2. Effect of Percent Succinylation on Buffering Capacity of zPEI 
As described in chapter one, the buffering capacity of polycations is not only 
indicative of the charge density due to amine groups, but also has been proposed to 
influence the mechanism that polyplexes are able to escape the endosomal compartments 
in target cells.  To better characterize the effect of succinylation upon the buffering 
capacity, titrations on 0.4 mg/mL solutions of our modified zPEIs, along with unmodified 
PEI and water.  The ability of zPEI to buffer aqueous solutions is related to the amine, 
amide, and carboxylic content of the modified polymers.  As previously described in 
section 1.2, the amine groups of PEI possess a wide range of pKa, beginning at 9.98 and 
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decreasing as protonation of amines increases. 22, 29  Carboxylic groups typically buffer at 
much lower pH, having pKa ~ 4.  Additionally, amides buffer at a pH of ~ 0.  Therefore, 
the buffering capacity of zPEI should be proportional to the substitution ratios, as 
characterized by H-NMR.  The titration curves are shown in figure 2.4.  As percent 
substitution increases, the titration curves shift to the left, indicative of a reduction in ability 
of the polymers to buffer over the pH range tested.   
Extent of buffering capacity was estimated as the number of µmol of HCl necessary to 
shift the pH of the PEI solutions from 7.4 to 4.  This ph range was chosen because it is the 
relevant range of buffering between extracellular pH and the acidic pH of endosomal 
Figure 2.4 Titration of zPEI Derivatives with HCl.  Prior 
to measurement, all samples titrated to a pH of 11.5. 
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compartments.  Table 2.1 below shows the buffering capacities of zPEI as compared with 
the unmodified and water.  Buffering capacity was calculated as follows:   
𝛽 = 	 $%&'()*
|∆-.|(0123345)
   (Equation 2.1) 
The buffer capacity, b, is expressed in terms of µmol strong acid per L buffer solution.  For 
all but between 8.0% and 15.4% substituted zPEI, the buffering capacity between pH 7.4 
and 4.0 decreases as percent substitution increases.  It is likely that no difference in 
buffering capacity between 8.0 % and 15.4 % zPEI was detected because of the simplicity 
of the calculation in addition to limitations in resolution of our titration.  
2.3.2. Characterization of Complex Formation and Dissociation 
2.3.2.1. Complex Formation and Dissociation of zPEI 
Agarose gel electrophoresis was used to characterize the binding affinity and 
polyplex stability of our zPEI/DNA and uPEI/DNA polyplex nanoparticles.  For all percent 








Table 2.1 Extent of buffering of succinylated bPEI derivatives
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modification, DNA migration in the gel is markedly retarded with increasing uPEI or zPEI 
concentration, showing that all PEIs investigated are capable of condensing DNA.  We 
hypothesize that both polyplex condensation and complex stability will be highly 
dependent on the percent succinylation in the zPEI samples. 
In agarose gel electrophoresis, a current is passed through an electrolyte containing 
solution through a polymerized gel.  DNA samples are negatively charged, so when 
exposed to an electric current, DNA will migrate away from the negative cathode and 
towards the positive anode.  Due to steric constraints when diffusing through the 
polymerized agarose it was loaded, smaller DNA molecules will diffuse more quickly than 
larger ones. For this reason, agarose gel electrophoresis can be used to separate and 
visualize molecules both by charge and mass.  A simple schematic of an agarose gel setup 
is shown below in figure 2.5a.  DNA containing agarose gels are often stained with 
ethidium bromide, and intercalating agent, in order to fluorescently image the location of 
DNA bands following running of the gel.  In figure 2.5b, a typical agarose gel image of 
pUC19, a 2686 base pair containing plasmid, is shown.  The supercoiled, or tightly wound 
and compacted variant of the plasmid is labelled s, and it diffuses further than the band 
labelled n and l, representing the nicked open coiled and linear conformation of the 
plasmid, respectively.  The presence of damaged plasmid (bands n and l) in the commercial 
plasmid is a result of the method of synthesis and purification of the DNA.    
Gel retardation assay was used to visualize the disappearance of plasmid DNA 
bands with increasing amounts of polymer to quantify the relative affinity of zPEI for  
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binding DNA.  As the amount of polymer added to DNA increases, the amount of free 
DNA in solution will decrease.  When run in a gel with progressively increasing amounts 
of polymer, the effect will be a disappearance, and in some cases a smearing, of the DNA 
bands.  DNA polyplexes gain positive charge, and are unable to migrate towards the 
positive anode.  For this reason, bound DNA either becomes entrapped in the loading wells, 
or diffuses towards the negative cathode, out of the gel.  Smearing is presumably observed 
due to the presence of noncondensed DNA molecules which are still interacting in some 






























Figure 2.5. a) simple schematic of agarose gel electrophoretic on plasmid 
DNA.  b) representative gel bands of the supercoiled (s), nicked open 
coiled (n), and linear variants (l) of pUC19 plasmid next to a 1 kB DNA 
ladder 
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Shown in Figure 2.6, is the gel retardation assay of 0.2 µg pUC19 with varying 
weight ratios of uPEI and zPEI. The plasmid DNA exists primarily in the supercoiled form.  
For uPEI, complete condensation was observed by electrophoresis at weight ratios of 2 
(N/P = 15.4) as visualized by the complete disappearance of the supercoiled band in the 
gel in Fig. 2.6A. As anticipated, more zPEI was required for complete condensation with 
increasing percent modification.  A weight ratio of approximately 6 is necessary to 
visualize disappearance of DNA bands in 35.0% succinylated PEI (Fig 2.6F).  There is 
some ambiguity between 8.0% and 15.4% succinylated PEI which may suggest 
imperfections in our H-NMR characterization (Fig. 2.6C-D).  It is also possible that 
different substitution ratios differ in the numbers of primary and secondary amines that 
reacted to form succinyl groups.  Differences in the location and distribution of charge on 
the surface of the polymer, or on the inside could lead to varying properties of complexation 
with DNA.  These results reveal that the zPEI samples examined were able to condense 
plasmid DNA.  However, with increasing percent succinylation, more zPEI was required 
to fully condense the DNA.   
Polyplex stability was also examined using a gel shift assay.  Through the addition 
of a polyanion competitor, polyplex DNA can be released and visualized by gel 
electrophoresis.  The amounts of competitor required to release DNA is then directly 
related to the stability of the complex.  Here, we have used dextran sulfate (DS) as our 
competitor polyanion.  DS was found to be both cheaper and more effective in DNA release 
compared to another commonly used competitor, heparin sulfate. uPEI and zPEI 
polyplexes were formed as discussed previously.  Since the highest required weight ratio 
for 35% zPEI/DNA was observed to be 6 (Fig 2.6); all DNA release assays were performed 
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at this weight ratio.  DNA release assays upon addition of DS is shown in Figure 2.7uPEI 
shows complete release after a weight ratio of 10 DS to DNA. zPEI shows release is 
dependent on the degree of succinylation in the condensing agent. For zPEI, less competing 
Figure 2.6. Gel retardation assay of zPEI complexation with pUC19 plasmid. A) 
Unmodified bPEI  B) 5.8% zPEI  C) 8.0% zPEI  D) 15.4% zPEI  E) 26.7% zPEI  F) 
35.0% zPEI  
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Figure 2.7. Dextran Sulfate Release Assay of zPEI complexation with pUC19 plasmid. 
Complexes formed at weight ratio PEI/DNA of 6.  A) Unmodified bPEI  B) 5.8% zPEI  
C) 8.0% zPEI  D) 15.4% zPEI  D) 26.7% zPEI  E) 35.0% zPEI
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polyanion (DS) is required to release DNA with increasing percent modification of the PEI. 
Like the previous figure, there is some ambiguity between 15.4% zPEI and 26.7% zPEI, 
which seem to show the opposite trend in Figure 2.7.  In a similar fashion to what was seen 
with the binding gels of zPEI, this may suggest inadequacies in our current methods of 
characterization between these two polymers.  In particular, it is possible that the 15.4% 
zPEI contains a different ratio of substituted primary and secondary amines.   
The colloidal properties were also investigated for these polyplexes using dynamic 
light scattering (DLS) and Zeta potential measurements to characterize the size and charge 
of zPEI/DNA polyplex nanoparticles.  DLS correlates the scattering of light off of particles 
in solution with Brownian motion in order to measure the magnitude and variance of the 
hydrodynamic radius of molecules.71    Zeta potential analysis correlates the Doppler shift 
in frequency of scattered light off of particles in solution under an applied current from an 
electrode.72  This allows for quantification of a “zeta potential” (mV) which is directly 
related to the sign and magnitude of particle surface charge.72  Polyplexes were prepared 
at a PEI/DNA weight ratio corresponding to the optimal conditions for transfection, as 
established in HeLa cell cultured performed by the Pack laboratory.73  The measured values 
for radius and zeta potential are shown below in table 2.2.  No clear trend was evidenced 
from this data as a function of the degree of modification.  All particles, except for the 
26.7% zPEI, had radii under 300 nm, indicating that zPEI molecules are still suitable for 
cell uptake in delivery applications.  The radii of zPEI are larger in scale than the 
unmodified polymer, likely due to the reduction in positive charge density in DNA/PEI 
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particles, which reduces the electrostatic repulsion between molecules.  The zeta potential 
of all zPEI derivatives, except for 35% zPEI, remained cationic.  Only 35% zPEI shows a  
charge reversal resulting in an observed negative zeta potential.  We hypothesize that as 
positive amine groups are removed by succinylation, neighboring unreacted amine groups 
pKa groups are likely to shift upwards, so that even as amines are removed, and negative 
succinyl groups are added, the charge of PEI at physiological pH is able to remain net 
positive.  Only in the 35% substituted zPEI, did the addition of negative charge overwhelm 
the positive charge of the polyplex.  This is similar to what was observed in acetylated PEI 
derivatives by Gabrielson, et al. where acetylated PEI derivatives were able to condense 
DNA with positive charge and radii below 300 nm.22   It is likely that the large particle 
sizes observed in the 26.7% zPEI and negative potential in the 35.0% zPEI are due to the 
addition of zwitterionic character, in contrast to just the removal of amine groups in 
acetylation.  It is surprising that particle formation between 35% zPEI and DNA only 
Sample Radius	(nm) Zeta	Potential	(mV) Optimal	w/w	PEI/DNA*
uPEI 61.3	± 10.3 15.1 ± 2.0 1
5.8%	zPEI 174.4	± 9.68 15.0	± 1.8 2
8.0%	zPEI 286.6	± 2.8 11.9	± 2.1 4
15.4%	zPEI 205.3	± 2.8 9.62	± 1.2 4
26.7%	zPEI 669.8	± 37.76 11.8	± 1.8 4
35%	zPEI 139.6	± 14.6 -1.3	± 1.4 4
Table 2.2 DLS and Zeta Potential Measurement of zPEI Derivatives
* Determined by Logan Warriner (Chemical and Materials Engineering) by HeLa transfection
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produces particles of around 140 nm, even though the net charge on the polyplexes is 
negative.   
2.3.2.2. Comparison of binding and release properties of a charge neutral modification 
Modulation of polymer/DNA interactions by replacement of positive charge with 
charge neutral groups has proven to improve the transfectability of cationic polymers.   In 
particular, the Pack group have shown that the acetylation of PEI can increase the 
transfection efficiency of PEI by 58 fold.21-22  A simple schematic of this reaction is 
illustrated below in figure 2.8.  In order to compare the effect of addition of charge neutral 
groups to our zwitterionic modification, identical binding and release agarose gel assays 
were run on acetylated PEI (acPEI).  Several substitution ratios of acetylated PEI (33.0%, 
57.1%, and 93.1%) were provided by the Pack lab and synthesized and characterized as 














Figure 2.8 Reaction scheme for the synthesis of acetylated PEI using acetic 
anhydride.  Reaction is also possible with secondary amines, but for simplicity, only 
substitution upon primary amines are shown.   
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instead of replacing the positively charged amine group of PEI with a negative succinyl 
group, it is replaced with a neutral acetyl group.   
The binding gels for acPEI are displayed in figure 2.9 below.  A polymer to DNA 
weight ratio of 1.75 is required to visualize the complete binding up of pUC19 by 17.1% 
acPEI, and a weight ratio of 2.5 is necessary to see complete binding by 37.4% acPEI. The 
release gels of acetylated PEI are displayed below in figure 2.10.  As acetylation increases, 
the amount of dextran sulfate required to cause the full release of DNA also increases.  
Figure 2.9. Gel retardation Assay of acPEI complexation with pUC19 plasmid. 
A) Unmodified bPEI  B) 17.1% acPEI  C) 37.4% acPEI D) 68.4% acPEI
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In contrast to zPEI, acPEI condenses pDNA fully at much lower weight ratios 
suggesting a higher affinity for binding.  For example, 37.4% acetylated PEI required a 
weight ratio of 2.5 to completely condense pUC19 compared to nearly double this amount 
to fully condense the plasmid with the comparable 35% zPEI.  In addition, the stability of 
the acPEI/DNA complex is also higher requiring significantly more dextran sulfate to 
Figure 2.10. Dextran Sulfate Release Assay of acPEI complexation with pUC19 
plasmid at a PEI/DNA weight ratio of 6. A) Unmodified bPEI  B) 17.1% acPEI  C) 
37.4% acPEI D) 68.4% acPEI  
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release the DNA.  The release of 17.1% acPEI occurs at a DS/DNA ratio of 7.8, which is 
roughly double the weight ratio of DS required to release 15.4% zPEI.  This effect is even 
more obvious for higher degrees of modification.  37.4% acPEI/DNA requires roughly 10 
fold more dextran sulfate to release DNA compared to 35% zPEI/DNA.  Taken together, 
this data suggests that succinylation represents a more potent method of modulating DNA 
binding and release character than acetylation.   
2.3.2.3. zPEI leads to improved transfectibility and lowered cytotoxicity in HeLa cells 
Transfection studies in HeLa cells, performed by the Pack lab, revealed that not 
only do low percent modified zPEI (5.8%, 8%, and 15.4%) lead to higher transfection 
efficiencies in a serum-free transfection environment, but zPEI is able to achieve 
efficiencies exceeding the unmodified polymer in serum.73  Surprisingly, 5.8% modified 
zPEI in-serum is able to outperform the efficiency of transfection of uPEI in a serum-free 
environment, a rarely seen trait with chemical transfectors. These results have been 
replicated in other cell lines including MC3T3-E1 (mouse preosteoblast) and MDA-MB-
231 (basal like breast cancer cell) where weight ratios were varied to determine an optimal 
transfection weight ratio. In order to better understand how succinylated PEI leads to higher 
transfection efficiencies, dextran sulfate release gels were run on each zPEI system at their 
optimal transfection weight ratios (serum-free HeLa transfection) with respect to DNA.  
The results are shown below in figure 2.11.   
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Interestingly, the release character for each of the polymers was somewhat similar.  
This suggests that affinity for release is quite alike at the optimal conditions for each zPEI.  
By adding more or less polymer, the release point of DNA can be tuned, and by adding 
Figure 2.11. Dextran Sulfate Release Assay of zPEI complexation with pUC19 
plasmid.  Complexes formed at weight ratio PEI/DNA corresponding to the optimal 
transfection efficiency (Determined by Logan Warriner).  A) Unmodified bPEI (w/w 1) 
B) 5.8% zPEI (w/w 2)  C) 8.0% zPEI (w/w 4)  D) 15.4% zPEI  D) 26.7% zPEI (w/w 4)
E) 35.0% zPEI (w/w 4).
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zwitterionic character, the release point can be maintained while modulating other 
behaviors of the polymer, such as cytotoxicity or binding to serum components.  
Cytotoxicity studies by the Pack lab reveal that increasing zwitterionic character leads to a 
reduction in cell death when polymer is added to cells.73  This, in addition to the in-serum 
transfections that showed superior efficiency compared to the unmodified indicate that 
these polymers are able to be modified without losing DNA binding affinity at optimal 
conditions. The derivative with the largest deviation from the release point of the 
unmodified was 5.8% zPEI.  This also happened to be the transfection agent with the 
highest efficiency both in and out of serum.73  Out of serum, this polymer performed 
roughly 5 fold better in transfection efficiency at a w/w ratio of 2 compared to the 
unmodified at its optimal w/w of 1.73	 Additionally, large improvements in efficiency were 
seen using in-serum transfection conditions.  It is possible that this derivative, which holds 
DNA more tightly than the unmodified at its optimal weight ratio for out of serum 
transfections, reached a more ideal balance of binding character to cytotoxicity and 
resistance to nonspecific binding.    
2.4. Conclusions 
We report here a post polymerization reaction on branched PEI through 
succinylation with succinic anhydride.  Our spectroscopic analysis, in combination with 
titration data and zeta potential analysis, confirm the creation of an array of succinylated 
zwitterionic “zPEI”. We have shown that zPEI is capable of binding and condensing DNA, 
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forming stable nanometer scale colloidal particles, which are then capable of efficient cell 
transfection.  Percent modification is correlated with a loosening of charge based 
interaction between DNA and the polymer, affecting both affinity for binding in addition 
to extent of release.  Zwitterionic modification has been shown to modulate charge based 
interactions more aggressively than a similar acetylation reaction (acPEI), requiring lower 
substitution ratios to observe a similar effect upon particle formation and dissociation.  
These findings, in accordance with cell work performed by our collaborators in the Pack 
lab, suggests that charge reduction, along with addition of zwitterionic character, represents 
pathways towards creation of improved chemical gene delivery agents.   
Future work need focus on better characterization and modulation of substitutions 
onto polymer amine groups.  Since PEI is made up of primary, secondary, and tertiary 
amines, all distributed in different environments within the branched polymer structure, 
understanding to what extent different amine types are substituted on will contribute to a 
holistic understanding of the effects of post polymerization modification upon DNA 
interaction properties.  In addition, it may be possible to tune reaction conditions to favor 
substitution upon different PEI amine groups, whether they be internal vs. external, or 
primary vs secondary amines.  Biophysical, along with cellular characterization of 
polyplexes made up of varying amine containing PEI derivatives will further the 
understanding of a structure function relationship in cationic transfection agents.   
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Chapter 3: Analysis of Internal Structure of zPEI/DNA 
Complexes by Small Angle X-ray Scattering 
3.1. Introduction 
Chemical transfection agents, such as branched polymer polyethylenimine, have 
emerged as strong candidates for use in non-viral gene delivery due to their readily modular 
chemical properties in addition to a lower risk for immunogenicity. Previous literature has 
shown that chemical modification of PEI, such as PEGylation, alkylation, or the use of 
ternary polyanion/Polycation/DNA complexes, lead to reduced cytotoxicity in addition to 
improved transfection in cell cultures.12-25  We have recently shown that the addition of 
zwitterionic charge through succinylation of the amine groups of branched 
polyethylenimine leads to altered binding and release properties of DNA (chapter 2).  Cell 
work in collaboration with the Pack lab has revealed both a reduction in cytotoxicity and 
an improvement in transfection efficiency upon succinylation for zPEI compared to 
unmodified PEI (uPEI) both in and out of serum.73	 
While chemical modifications in polyplex formulations has often been shown to 
correlate to improved transfection efficiencies, presumably to altered DNA binding 
behavior, the effects of such changes upon the internal structure of polymer/DNA 
complexes has not been well established.  Design of more efficient materials requires better 
understanding of both polymer-NA interactions and how the internal structures in polyplex 
nanoparticles relates to intracellular trafficking and gene delivery efficiency. In this study, 
we use small angle x-ray scattering (SAXS) to characterize the effect of succinylation on 
zPEI/DNA polyplex formation and structure.  Because X-ray radiation lies between 0.01-
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100 angstroms, X-ray based techniques are often chosen to study structural information on 
condensed molecular systems such as crystals with characteristic distances on the scale of 
angstroms.74-75  SAXS is a variant of X-ray scattering used to study structural properties 
greater than 10 angstroms.74, 76  Spacing between crystal or semi-crystalline planes can be 
determined, and in many cases molecular spacing as well as organization structure may be 
elucidated.76  SAXS shows great flexibility with respect to sample preparation, as the 
sample analyzed need not be a true crystal, and can be powders, liquids, or DNA 
suspensions such as those studied in this work.74, 76-77  Previous studies have shown 
mixtures of DNA and polycations (≥ +3),  typical leads to self-assembly of the DNA 
helixes into a hexagonal lattice (representative image in figure 3.1 below).77 These DNA 
helices are not touching, but rather separated by 5-15 Å of water.  The DeRouchey lab, and 
others, have shown that the interaxial DNA spacings inside the condensates are highly 
dependent on cation chemistry. In this Chapter, we use SAXS to determine the DNA 
packaging as a function of percent zwitterion modification in zPEI/DNA and compare it to 
unmodified PEI/DNA. We also use SAXS to monitor intermolecular assembly over time 
for zPEI and uPEI polyplexes.   
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3.2. Background on Small Angle X-ray Scattering 
3.2.1. Generation of X-rays 
Radiation with wavelengths between 0.1 and 100 angstroms are termed X-rays.  
Because these values are comparable in magnitude to the length of bonds and other 
interactions in condensed state materials, they are often used in diffraction experiments to 
characterize structure of said materials.74-75  Ka radiation, with wavelength of 1.5418 
angstroms is one of the most common wavelengths used in X-ray experiments,  and is 
generated from electron bombardment of a copper target in an X-ray tube.74-75  In this 
method of generation, commonly used for benchtop style X-ray scattering setups, a heated 
tungsten filament is used as a cathode, and a negative voltage is applied.70 This results in 
the ejection of electrons, which are attracted to the anode due to a positive current applied, 
which is attached to the target metal.74 Electrons striking the target metal result in X-ray 
production from two main mechanisms.  The first is a broad range of wavelengths resulting 
Figure 3.1. Polycationic complexes have been shown to pack into 
hexagonal lattice conformations.   
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from the deceleration of electrons as they impact the target metal, termed bremsstrahlung 
(“brake radiation”). 74-75    Second, sharp peaks, or “characteristic radiation” is produced 
when impacting electrons result in ejection of core electrons from the metal target. 74-75  As 
higher energy electrons fall to fill this vacancy, photons with characteristic wavelengths 
(specific to type of metal used as target) are emitted depending upon which subshell 
electrons move from. 74-75  Because the impact of electrons generates heat, the amount of 
power applied to the tube and, consequentially the output of radiation, is limited.  This can 
be partially overcome by using a rotating anode to limit heat buildup on the anode, or a 
liquid cooling system may be employed.74   An alternative to X-ray tube setups capable of 
much higher radiation output, which allows for shorter periods of measurement and higher 
resolution, is use of a synchrotron source.74 In this setup, electrons are radially accelerated 
on a circular track at speeds just below the speed of light.74 The acceleration of the charged 
electrons produces a broad spectrum of high powered radiation.74 In either synchrotron or 
tube based setups, output radiation must often be filtered to include only the wavelength 
range of interest to the experimenter.  Often this is accomplished by nickel filtration, the 
use of crystal monochromators, or polycrystalline filters.74   
3.2.2. Small Angle X-ray Scattering (SAXS) Theory 
In order to discuss X-ray scattering experiments, terminology used must be 
carefully established.  When X-ray radiation impacts a sample, the radiation is displaced 
in all directions by the electrons in the sample, termed scattering.74    When X-rays are 
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scattered by a sample possessing order, such as a crystal or a polycrystalline material, the 
scattered rays interfere either constructively or destructively with each other, limiting 
which scattered angles can be detected.74  This scattering and resulting interference in 
ordered samples is defined as diffraction.74  It is common, however, to interchangeably use 
these terms, especially when discussing techniques such as small angle scattering (SAXS) 
or wide angle scattering (WAXS), both which make use of diffraction.74  X-rays, like all 
electromagnetic radiation, possess both wave and particle behavior.74  They propagate 
through space as waves with electronic and magnetic components, both with periodically 
repeating amplitudes (over the course of 1 wavelength).70, 74, 78  In order for constructive 
interference to occur, parallel photons of light must have overlapping wave functions.70, 74,
78  In X-ray scattering experiments, a wavelength of radiation is chosen that is on the same 
magnitude as the spacing of ordered structures in the samples.74  Figure 3.2 portrays X-ray 
beams impacting a sample of ordered lattice structure with interplanar distance 𝑑89:;;.70 
Radiation scatters off of the top most plane at an atom/molecule at point Z, and off of the 
second plane at point B.  
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In order for the two wave functions to overlap and constructively interfere with one 
another, the additional distance travelled by the light scattered off of point B must be equal 
to some integer multiple of the wavelength.70  
AB + BC = nl                                         (Equation 3.1) 
Since AB and BC are equal to 𝑑89:;;sinq, the conditions for constructive interference can 
be summed up by the following equation70:  
nl = 2𝑑89:;;sinq                            (Equation 3.2) 
This is known as Bragg’s law, and defines at what angles diffraction can occur.  For 
crystalline samples made up of one orientation of ordered packing structure, this would 
result in defined points of diffraction on a flat imaging surface.  When a sample is made up 
of many orientations of the same unit structure; such as powders, liquids, or the DNA 
Figure 3.2. Representation of radiation scattering off of a crystalline 
packing pattern.  Image based upon Figure 12-6 (pp. 279) in chapter 12 
of Skoog, Holler, and Nieman’s Principles of Instrumental Analysis (5
th
ed).  Radiation depicted as orange dotted lines scatters off of molecules Z 








suspensions examined in this study, the projected diffraction image will be a ring of a radius 
proportional to the angle of scattering.  If the distance between the detector and sample is 
known, the angle of scattering can be established, and 𝑑89:;;	can be calculated using 
Braggs law.  Standards, such as silver behenate, with defined series of Bragg spacings, are 
commonly used to calibrate the sample to detector distance for SAXS.79-80  If the unit cell 
type can be established, distance between molecules can be calculated from the 
𝑑89:;;	value.  For instance, in a hexagonal lattice unit cell, such as those observed in 
polycation/DNA complexes, the interhelical spacing (𝑑<=>) of DNA molecules represented 




𝑑89:;;                                  (Equation 3.3)
Scattering experiments are usually divided into 3 categories based on angles of 
diffraction measured: wide angle x-ray scattering (WAXS) is the measurement at angles 
greater than 10°  (dBragg < 1 nm), small angle x-ray scattering (SAXS) the measurement of 
angles between 0.1 and 10° (100 nm > dBragg > 1 nm), and ultrasmall angle x-ray scattering 
(USAXS) the measurement of angles less than 0.1° (dBragg > 100 nm).76  To measure 
smaller angles, the distance between the detector and the sample must be longer.  Because 
the angle of scattering is inversely proportional to the spacing of the unit cell planes, the 
dimensions of image projected onto the detector are inversely proportional to the 
dimensions of the material being imaged.  For this reason, it is often useful to describe the 
dimensions of the image in units of inverted distance, or inverse space.  In our experiments, 
we use q (nm-1) to describe the magnitude of radial scattering: 
 q = ApB<=q
l
                                      (Equation 3.4) 
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3.3. Materials and Methods 
3.3.1. Materials 
In addition to the synthesized zPEI described in chapter 2, the following materials 
were also used.  10 mM tris (400 µM NaN3) was prepared from Tris HCl purchased from 
Madiatech, Inc (Manassas, VA) and sodium azide from Sigma Aldrich (St. Louis, MO).  
Calf-thymus DNA was purchased from Sigma Aldrich (St. Louis, MO) and suspended in 
10 mM tris (400 µM NaN3) as recommended by the manufacturer.   
3.3.2. Sample Preparation 
Concentrated PEI solution (0.5-1 mg/ml) was added to 300 µg of calf-thymus (CT) 
DNA suspended in 10 mM tris buffer (400 µM NaN3) to the desired PEI/DNA weight ratio 
resulting in complete condensation of DNA.  UV/Vis of the supernatant confirmed 
complete DNA condensation.  Samples were made in triplicate.  Samples were allowed to 
incubate at room temperature for 30 minutes, then centrifuged at 10500 g for 10 minutes.  
The condensate gives a white pellet. The condensate was then removed by a glass rod and 
placed in 1 mL of 10 mM tris (pH 7.5) buffer and allowed to equilibrate. Samples were 
measured after 1 hour, 1 day, 1 week, 3 weeks, and 1 month of incubation.  For SAXS 
measurements, equilibrated pellets were placed in a home designed Teflon sample holder, 
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sealed between Mylar windows in fresh buffer, and measured as described in the 
instrumental setup section.  For time series measurements, after x-ray exposure, samples 
were placed back into fresh 1 mL Tris buffer to equilibrate further until subsequent 
measurement. In order to determine sample to detector distance, silver behenate was 
mounted in the same sample holder and exposed to x-ray radiation.   
3.3.3. Instrumental Setup 
A Nonius FR-591 rotating-anode fine-focus X-ray generator (45 kV and 20 mA) 
was used to produce CuKa radiation (1.54 Angstroms).  Detection was imaged using a 
Bruker SMART-6000 Phosphor CCD detector.  The teflon sample holder was placed in a 
steel holder (figure 3.3a) to mount the DNA pellet in the path of the source radiation.  The 
pellet was placed in the top of the triangular open window on Teflon holder A, in buffer.  
This window was flanked by Mylar films to hold the sample within the holder. The 
sandwich assembly was then placed inside of the steel sample holder, with the triangular 
portion pointing down, so that the DNA pellet was aligned through the small circular hole 
in the holder.  This was mounted between the radiation source and the detector with the x-
ray beam aligned to allow passage through the sample.  A helium chamber was placed 
between the sample and the detector to minimize scattering from air.  At the back of the 
helium chamber, a lead beam stop was used to prevent the direct beam from reaching the 
detector.  Samples were typically exposed for 2 minutes.  A photo of this setup is displayed 
in figure 3.3b.  Once imaged by the detector, Fit2D software was used to radially integrate 
51	
the circular diffraction patterns.  Origin software was subsequently used to plot scattering 
profiles and determine Bragg peak positions. A representative SAXS diffraction pattern of 
PEI/CT-DNA polyplex is shown below, along with a radial integration displayed in units 







Chip A Chip B (x2)
Steel mount
Figure 3.3. A. The teflon chips and steel mount used to 
hold the polyplex pellet in place.  B. SAXS setup used to 




3.4. Results and Discussion 
In order to better understand the packing of PEI/DNA complexes as a function of 
percent succinylation, a series of SAXS samples were made and measured at various time 
points over a period of 1 month.   In addition to the unmodified, 5.8 %, 8.0 %, 26.7 %, and 
35.0 % zPEI were all measured after 2 hours, 25 hours, 1 week, and 1 month.  
Representative scattering profiles of each zPEI/DNA complex are shown below in figure 
3.5.  A collection of representative samples observed after 1 week of incubation is shown 
below in figure 3.6.  Bragg spacings are observed to vary considerably with zwitterionic 
character.  At lower percent substitutions (5.8 % and 8.0 %) the Bragg spacings are 
Figure 3.4. Left:  Scattering diffraction pattern of a PEI/DNA polyplex 
complexed at a weight ratio of 1.5.  A beam stop is visible as a dark diamond. 
Right: Radial integration from the center of the imaged scattering profile. A 




increased above those measured for unmodified PEI.  This is consistent with previous 
results by the DeRouchey lab using arginine peptides which showed the insertion of a 
negative moiety greatly increased the intermolecular repulsions resulting in significantly 
larger interaxial DNA spacings.81  Surprisingly, at 26.7% and 35.0% succinylation, this 
trend is reversed, and DNA-DNA spacings decrease significantly below even unmodified 
PEI-DNA.   
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A plot of Bragg spacings for each sample after 1 week is shown below in figure 
3.7.  While binding and release gels discussed in chapter two behaved as expected with 
increased zwitterionic character leading to reduced strength of DNA interaction, these x-
Figure 3.5. Plots of intensity vs. Q (nm
-1
)  for PEI derivatives complexed with
CT-DNA  a. unmodified PEI w/w 1.5  b. 5.8% zPEI w/w 2  c. 8.0% zPEI w/w 3.1 
d. 26.7% zPEI w/w 4.1  e. 35.0% zPEI w/w 6.1.  Weight ratios chosen that











ray results are unexpected.  Previous work in the DeRouchey lab on a similar system, a 
succinylated variant of the cationic dendrimer G4 polyamidoamine (zPAMAM), visualized 
a time and substitution % dependent phase transition.  When unmodified G4 PAMAM and 
CT-DNA were mixed at “low salt” conditions, similarly to how zPEI samples were 
prepared in this study, two distinct peaks were visible during the first two weeks of 
incubation.81  These peaks were consistent with a columnar square lattice and a columnar 
hexagonal lattice.  Over a few months, the square lattice peak disappeared and only the 
energetically favored hexagonal phase was observed.  The use of a high salt preparation 
was observed to overcome this barrier resulting in only a hexagonal phase being observed.  
Figure 3.6. Plots of intensity vs. Q (nm
-1
)  for PEI derivatives complexed
with CT-DNA following one week of incubation. Weight ratios chosen 
that resulted in complete binding of DNA. 
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Interestingly, the zPAMAM/DNA samples even prepared with the high salt preparation 
showed the same biphasic behavior as the low salt prepared PAMAM/DNA.  With 
increasing percent modification, the dominant Bragg peaks observed in zPAMAM/DNA 
shifted from the hexagonal phase to the square lattice phase.    One possible explanation 
for the changing trends in DNA-DNA spacings with zPEI percent modification could be a 
phase transition resulting in a smaller DNA-DNA spacing.  Unfortunately, all of the SAXS 
spectrum taken on zPEI/DNA only contained one Bragg peak making it difficult to 
ascertain information related to the DNA lattice in zPEI.  As the packaging in zPEI/DNA 
is unclear, for comparative purposes, all measurements reported in this chapter are given 
as the phase-independent Bragg spacings instead of the interhelical spacings calculated for 
a hexagonal lattice.   
The square lattice phase observed in G4 zPAMAM occurs at a larger Bragg spacing 
than the hexagonal DNA lattice.  Similarly, one would predict for a similar transition in 
zPEI, we would observe an increase in the Bragg reflection.  However, for the higher 
percent modifications (26.7% and 35%) we see the opposite with DNA-DNA spacings 
being even smaller than unmodified PEI/DNA.  G4 PAMAM contains 256 primary amine 
groups localized to the outside of the branched dendrimer.  Since DNA likely shows 
preferential interaction with the outer primary amines as opposed to the uncharged tertiary 
amines on the inside of the dendrimer, the interactions and conformational shifts between 
the dendrimer and DNA are likely very different from those observed in a branched PEI 
molecule, which can interact with DNA through both primary and secondary amines 
located both on the outside and inside of the random branching structure.  
57	
Plots of 𝑑89:;; vs time for all samples measured are shown in figure 3.8. 
Unmodified PEI, along with 5.8 % and 8.0 % zPEI, show a time dependent rearrangement 
of approximately 5% over one month to smaller DNA-DNA spacings.  Samples of 26.7% 
and 35.0% zPEI, however, show significantly less rearrangement over time, reaching a 
stable conformation in under 24 hours.  This suggests that the zwitterionic character of the 
zPEI is reducing kinetic energy barriers allowing for faster equilibrium structures to be 
achieved over significantly shorter time scales.   
Figure 3.7. Bragg spacings of zPEI samples collected after 1 week 
incubation. Each sample complexed at a weight ratio that resulted in complete 
DNA binding.   
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3.5. Conclusions and Future Work 
The internal structure of succinylated PEI/DNA polyplexes were investigated by 
SAXS analysis.  At lower polymer substitution ratios, increased succinylation appeared to 
cause an increase in the Bragg spacing of complexes, which can be interpreted as an 
opening of polyplex structure due to loosened charge interactions.  Unexpectedly, at higher 
substitution ratios, zPEI complexed DNA at lower Bragg spacings than observed with the 
Figure 3.8. Bragg spacings of zPEI samples collected over the course of 1 
month.  Each sample complexed at a weight ratio that resulted in complete 
DNA binding.   
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unmodified polymer.  Additionally, the higher percent modified zPEI complexes showed 
significantly shorter time scales to achieve equilibrium structures.  Taken together with the 
agarose gel studies (Ch. 2) which indicated loosened DNA/polymer interactions with 
increasing succinylation, these observations are surprising.  One possible suggestion is that 
higher percent modifications in zPEI result in a phase transition to a smaller DNA-DNA 
spacing in the condensates.   To better understand the kinetic barriers to polyplex structural 
rearrangement, and the effect of succinylation upon them, a “high salt” preparation, 
involving combining concentrated solutions of DNA and polymer in a 2 M solution of 
NaCl, may be performed on zPEI in the future.  The high salt concentration prevents the 
DNA from condensing, allowing both solutions to be mixed homogeneously.  
Condensation is induced by the addition of buffer, decreasing the salt concentration until 
DNA/polymer condensation occurs.  By allowing for homogenous mixing prior to 
condensation, this preparation was shown by DeRouchey et. al. to bypass the time 
consuming kinetic rearrangement of DNA/polycation complexes.77  Future work should 
also focus on better methods to accurately identify the nature of the succinylation reaction 
in zPEI and possible phase transitions.  Observation of possible higher order reflections to 
allow for assignment of DNA lattice would require a synchrotron source.  Orienting DNA 
samples may also improve scattering profiles.  With this type of instrumentation, it may be 
possible to differentiate different lines of symmetry within the structure, and properly 
determine lattice conformation as has been previously done by DeRouchey et al.77   
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Appendix Section:  Diffusion in Polymer Gels with Competing Interaction Sites 
A.1.  Introduction 
Biogels, made up of polymer networks diffusing in an aqueous environment, 
perform a variety of physiological functions in organisms, from the lubrication of joints to 
regulation of molecular diffusion.82    Fluids containing networks of carbohydrates and 
proteins make up biogels such as the extracellular matrix, epithelial mucus, and the basal 
lamina of blood vessels are able to regulate passage of messenger molecules, nutrients, 
pathogens and other substances to cells.82  Electrostatic interaction, in addition to steric 
filtration based upon size, has been determined to be one of the mechanisms utilized in 
filtration of biological fluids.83-84  In fact, studies on extracellular matrix and mucin 
hydrogels reveals that charge particles may be filtered based upon the magnitude of charge, 
rather than the sign of the charge itself.83, 85  Previous collaborative work between the 
laboratories of Dr. Jason DeRouchey (Chemistry department, University of Kentucky; 
Lexington, Ky) and Dr. Roland R. Netz (Physics department, Free University of Berlin; 
Berlin, Germany) have demonstrated the importance of attractive forces in limiting of 
diffusion of particles in charged hydrogels.86   
Because real biological fluids are heterogeneous mixtures of biopolymers with 
disparate chemical and physical properties; models that better approximate real biogels, 
containing both attractive and repulsive forces, must be constructed and experimentally 
validated.  To measure the diffusion of nanoparticles in solutions, such as polymer systems 
and tissues, fluorescence correlation spectroscopy (FCS) has previously been utilized. 86-91  
FCS allows for measurement of diffusion coefficients (D, µm2/s) of probe molecules 
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through time autocorrelation of detected fluorescent intensity fluctuations in a diffraction 
limited confocal volume.  FCS only measures diffusion of particles that fluoresce at 
wavelengths chosen, making the technique highly selective.  Additionally, the diffraction 
limited spot in solution measured can be on the order of fL, and the concentration of 
particles needed for accurate measurement ranges from pM-nM.  This allows for reduced 
material consumption in sample preparation as well as limited particle interactions in 
solution. 
Mixed charge gel solutions comprised of positive and negative dextran polymers 
were created and the diffusion of a negatively charged probe molecule (Alexa 488) was 
experimentally measured with FCS.  Experiments were subsequently compared to 
simulated models of mixed charged gels developed by the Netz lab. Their model 
approximates a mixed charge gel as sets of fibers with random distributions of charged 
“patches” of either positive or negative charge, and finds that particle trapping, and thus 
retardation of diffusion, occurs in locations of the gel containing high densities of charge 
opposite to that of the diffusing particle.92  Our experimental results were found to be in 
quantitative agreement with the model.   
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A.2. Materials and Methods 
A.2.1. Materials 
The following Dextrans were purchased through Sigma Aldrich: Dextran (Mw = 
500 kDa), Dextran (Mw = 15-25kDa), diethylaminoethyl-dextran (DEAE-dextran(+),Mw = 
500kDa) and Carboxymethyl-dextran (CM-dextran(-),Mw = 15-20kDa).  The 500 kDa and 
15-25 kDa dextrans are neutrally charged, while DEAE dextran possesses positively 
charged diethylaminoethyl groups, and CM dextran negatively charged carboxymethyl 
groups.  The following fluorescent dye molecules were purchased from Fisher Scientific: 
Alexa Fluor® 488 Succinimidyl Ester dye (Alexa488, Abs/Em peak: 495/519 nm), and 
Rhodamine 110 (R110, Abs/Em peaks: 496/520 nm).  The fluorescent molecules were 
readily soluble in water, and did not require purification prior to use.   
A.2.2. Preparation of Dextran Solutions 
Dextran stock solutions were prepared by dissolving solid dextran in 10 mM MES 
buffer (pH = 6.4) to a final concentration of 8-20 % w/v.  Solutions were allowed to mix 
for 24 hours following preparation to ensure homogeneity.  Stock solutions were used to 
prepare experimental samples of appropriate concentration by dilution into buffer to a final 
volume of ~500 µL.  These solutions were mixed and allowed to equilibrate for an 
additional 24 hours.  For mixed solutions of DEAE and CM dextran, stock solutions of 
each were added together to achieve the desired volumetric ratio of each dextran with 
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respect to total dextran.  Alexa 488 dye was added to a total concentration of ~5-10 nM, 
and this final solution was allowed to incubate, protected from light, for at least 6 hours 
before measurement to allow adequate dispersal of the dye molecule throughout solution.  
Samples were loaded into NUNC LabTek 8-well microscopy chambers (Nalge Nunc, 
Penfield, NY) prior measurement by FCS.   
A.2.3. FCS Setup 
An Alba fluorescent fluctuation system (FFS) confocal system was used for all 
fluorescence correlation spectroscopy (FCS) experiments.  A continuous wave 488 nm 
laser diode was used as an excitation source.  Excitation light was directed into 
experimental samples through a Nikon Ti-U microscope (60x/1.2 NA water-immersion 
objective lens).  Emitted light was passed through a 514-nm long-pass filter and a 50/50 
beam splitter into two pinhole equipped Hamamatsu H7422P-40 photomultiplier tubes for 
detection.  Confocal volume dimensions (w0 and z0) were determined through 
measurement of aqueous Rhodamine 110 at known concentrations (D = 440 µm2 s-1).93 
Routine realignments of detector pinhole/lens sets were performed with R110. In order to 
test solution homogeneity, reported results are the average of at least 9 measurements in 
different locations in solutions. Sampling times of 30 seconds were used for all 
measurements.  A sampling frequency of 200,000 Hz was used, which allowed 
autocorrelation over t > 5.0 µs.  All fitting was executed through VistaVision 4.0 software 
(VWR, Radnor PA).   
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A.2.4. FCS Data Analysis 
Many have already reported on the theory behind fluorescence correlation 
spectroscopy, so a brief synopsis will be described here. 94-95 The measured time traces of 
fluorescent events at all times (t) are compared for self-similarity after a lag time (t) by 
calculation of the normalized cross correlation, G(t): 
𝐺 𝜏 = 	EFG > HFG >IJ KL
EG > HLEG > KL
   (Equation A.1) 
𝛿𝐹(𝑡) and 𝛿𝐹 𝑡 + 𝜏 	represent deviation from the mean fluorescence < 𝐹 𝑡 > at time t 
and after time t + t.  Cross correlation between two different detectors ensures that the 
resulting autocorrelation is free from the effects of detector after-pulsing. 95 Assuming that 
all fluctuations are due to uniform fluorescent particles diffusing in and out of the confocal 
volume by Brownian motion, the following autocorrelation fit was used to model diffusive 
behavior:    













Where tD represents the dwell time of the particles in the confocal volume, whose shape 
can be approximated as a Gaussian ellipsoid with axial height z0 and equatorial width w0.  
N is the average number of particles occupying the observation volume.  The translational 




		 (Equation A.3) 
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In the case of spherical particles, the Stokes-Einstein equation can be used to relate the 





Here, kB represents the Boltzmann constant.  To facilitate visual representation and 
understanding, autocorrelations and fits can be normalized by dividing by G(0) and 
graphed with 𝜏\ on a logarithmic scale. 
A.3. Results and Discussion 
Fluorescence correlation spectroscopy (FCS) was used to measure diffusive 
properties of charged nanoparticles in solutions containing mixes of both positive and 
negatively charged polymers.  Alexa 488 was selected as a suitable probe molecule due to 
the -2 charge it possesses at a neutral pH.  Charged polymer solutions were made from 
DEAE Dextran (MW ~500 kDa, 1 DEAE (+) group per ~2 glucose monomers) and CM 
Dextran (MW ~13 kDa, 1 CM (-) group per ~4 glucose monomers).  To account for steric 
effects, Alexa transport in neutral Dextran was also measured.  Due to the differences in 
molecular weight between the DEAE and CM Dextrans, neutral dextran of comparable 
masses (500 kDa and 20 kDa, respectively) was examined.  For simplicity, the charged 
polymers will be noted as dextran(+) and dextran(-), and the neutral polymers as 
dextran500 and dextran20.  To ensure solution homogeneity, reported diffusion values for 
Alexa 488 are the average of 9 measurements in various solution locations.  All solutions 
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were prepared from solid dextran stocks without further purification other than that of the 
manufacturer.   
Normalized autocorrelations for pure solutions of dextran(+) and dextran(-) at 
different wt % ratios are shown in figure A.1.  Previous studies in the DeRouchey examined 
Alexa Fluor transport in Dextran(+) and dextran (-) solutions up to 8 wt%.  Here, we also 
examined higher wt% solutions up to 15wt%. As was previously observed by the 
DeRouchey lab, transport in DEAE dextran was slowest in low wt% solutions (e.g. 2 wt%) 
but the measured dwell times by FCS got shorter at higher wt%.  This trend continued at 
the high wt% solutions studied in this work.  The shift to faster diffusion at higher 
concentrations of DEAE dextran is likely due to higher concentrations of counter-ions 
carried along with the positive dextran, which would screen some of the charge interaction 
between the negative dye and the positive DEAE groups.86 Transport through pure 
dextran(-) solutions showed the opposite trend, in that as concentration of CM-dextran was 
increased, so too did the speed of diffusion.  Translational diffusion coefficients for Alexa 
488 in various unchared Dextran concentrations (% weight volume) is plotted in figure 
A.2.  Low wt % results are in very good agreement with the previous report.  Previously, 
the dextran stock had been dialyzed against ddH2O in order to ensure purity of materials 
and remove excess salt.86  As our diffusion values for non-dialyzed samples were nearly 
identical to dialysized dextrans, we showed that excess salt content or other contamination 
is very low and can readily be discounted as a source of experimental deviation. For the 
next studies, we therefore used Dextran solutions as received without dialysis and 
lyophilization. In dextran(+) solutions, diffusion of negative Alexa 488 is greatly reduced 
compared to the similarly massed dextran500, likely due to electrostatic interaction 
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between opposite charges.  Probe diffusion is roughly comparable between dextran(-) 
solutions and the neutral dextran20, suggesting attractive, rather than repulsive, 
B) 
A) 
Figure A.1.  Characteristic normalized FCS autocorrelation curves of diffusion of 
Alexa 488 NHS ester (-2 charge) through a 10 mM MES buffer (pH = 6.4) 
solution of (A) select wt% dextran (+) and (B) select wt% dextran (-).  
Experimental autocorrelations (symbols) are fit (solid lines) as previously 
described in order to acquire translational diffusion coefficients.    
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electrostatic forces play a large role in modulation of nanoparticle diffusion through a 
polymer solution.     
Mixed charge dextran solutions were prepared by addition of varying volumes of 
equal wt % solutions of dextran(+) and dextran(-) together, followed by mixing and 
incubation at room temperature overnight.  Charge mixing ratios are represented as volume 
of dextran(-)/total dextran volume.  For concentrations below 4% weight per volume (wv), 
mixing ratios of 0.75-0.9 volume dextran(-)/total dextran resulted in cloudy solutions that 
were inhomogeneous and unsuitable for FCS studies.  One possible reason for this is that 
at concentrations below 4% wv, the concentration of salt from the commercial Dextran 
stock are low enough in solution that the release of counter-ions into solution becomes an 
entropically favorable condition for complexation between the positive and negative 
Figure A.2. Translational diffusion coefficients (D) of Alexa 488 in 
increasing concentrations (% wv) dextrans.  All values acquired 
through fits of experimental FCS autocorrelations.  
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dextran to form a coagulate.  Representative FCS autocorrelation curves of Alexa 488 
diffusion through varying volumetric ratios of the positive dextran to the negative dextran 
at a total dextran concentration of 6% wv are shown in figure A.3.  Larger amounts of 
dextran(-) with respect to dextran(+) are necessary to shift the dwell times of the probe 
molecule.  This is at least partially explainable by the smaller number of monomers per 
charged group on dextran (+) compared to dextran (-).  However, the previous report on 
probe diffusion through charged dextran showed that repulsive charge between dye and 
dextran resulted in a small increase in 𝜏\	compared to neutral dextran, where an attractive 
force produced a significant increase in dwell time.86   It is therefore reasonable to assume 
that the observed imbalance between 𝜏\	and ratio of dextran(-) to dextran(+) are a result of 
both factors.  Translational diffusion coefficients for Alexa488 probe molecule in 4, 6, and 
8% wv mixed dextran solutions are shown in figure A.4 for various mixing ratios of 
Dextran(+) and dextran (-).   When dextran(+) and dextran(-) are mixed at a 1 to 1 ratio, 
diffusion coefficients are approximately the same as pure dextran(+).  Mixing ratios of at 
least 0.75 dextran(-)/total dextran are necessary to observe a shift in the translational 
diffusion coefficient away from that of the pure dextran(+) solutions of the same total 
dextran concentration, suggesting that the presence of positive charge largely determines 
the diffusive behavior of the negative nanoparticle through the polymer solution.  However, 
because translational diffusion values rise with increasing volume ratio of dextran(-)/total 
dextran, addition of negative charge does appear to screen the interaction between dextran 
(+) and the negative dye molecule. 
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Figure A.3.  Characteristic normalized FCS autocorrelation curves of 
diffusion of Alexa 488 NHS ester (-2 charge) through a 10 mM MES 
buffer (pH = 6.4) solution of 6% wt dextran at a variety of mixing 
ratios of equal concentrations of dextran(+) and dextran(-).  Mixing 
ratios expressed as volume of dextran(-)/ volume total dextran.  
Experimental autocorrelations (symbols) are fit (solid lines) as 
previously described to acquire translational diffusion coefficients.    
71	
The Brownian dynamics (BD) simulation proposed by the Netz lab consist of a 
series of parallel rods, 16 oriented along the x, y and z axis for a total of 48 rods per three 
dimensional network.92 Parameters are included for the Brownian motion of the particle, 
involving the internal energy and temperature, along with the distance between fibers 
(mesh size), diameter of the probe molecule.  Disorder could be introduced into the square 
lattice structure of this network by increasing a term controlling the standard deviation of 
rod placement. Sections of the rods, designated “patches” were randomly assigned to be 
positively charged or negatively charged.  A representative image of a disordered lattice of 
mixed charge is shown below in figure A.5.  Notably, the probe particles were shown to 
Figure A.4. Translational diffusion coefficients (D) of Alexa 488 in 4, 
6, and 8 % wv mixed solutions of dextran(-) and dextran(+).  D values 
are plotted against mixing ratio, expressed as volume of dextran(-)/ 
volume total dextran.   All values acquired through fits of experimental 
FCS autocorrelations.  
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slow with increasing polymer concentration in networks with equal concentrations of 
positive and negative charge in both disordered and ordered systems in support of this idea 
suggested from the results of Lieleg and others.83, 85     
In order to experimentally validate the BD simulation proposed, the model was 
tuned to match the parameters of the mixed charged dextrans measured by FCS.  By 
approximating the mesh size along with the charge per molecule, and the size and charge 
of Rhodamine 110, diffusion values for the mixing ratios and concentrations presented in 
figure A.4. were calculated.  These values plotted against the experimentally determined 
diffusion coefficients, are plotted below in figure A.6.  Calculated values are in quantitative 
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Figure 1. Tracer position snap shots (red spheres) at di↵erent times for simulations with randomly distributed,
competing interaction sites (left) and for purely attractive networks (right) with the same absolute value for the
interaction strength |U
0
| = 15 kBT , an interaction range of k = 0.5s and a e↵ective tracer diameter of s = 0.2b.
The top and bottom row figures show ordered networks with a disorder strength of d = 0 and disordered networks
with d = 0.9, respectively. The algebraic sign of the interaction potential along the fibers is indicated in red
(repulsive) and blue (attractive). The figures illustrate that the trapping mechanisms observed in networks with
competing interaction sites are the same as for purely attractive networks. For ordered networks (top figures) vertex
localization [17] is observed. In the lattice with competing interaction sites (top left), the degree of localization di↵ers
between the vertices and depends on the number of adjacent attractive patches. In the disordered lattices (bottom
figures) we observe dense fibers trapping [17].
3
Figure A.5. Snapshot of a disordered lattice BD simulation.  In 
locations of high negative charge (blue), the positive tracer is shown to 
localize, and become ensnared.  Reprinted with permission from 
Hansing, J.; Duke, J.R.; Fryman, E.B.; DeRouchey, J.E.; Netz, R.R. 
Diffusion in polymer gels with competing interaction sites, 2017. 
Manuscript to be submitted for publication. 
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simulated values appear to overestimate the diffusion of particles, likely due to a mis-
estimation in the effect of hydrodynamic hindrance.    
Figure A.6. Translational diffusion coefficients (D) of Alexa 488 in 4, 6, and 8 % wv mixed 
solutions of dextran(-) and dextran(+) presented against simulation data.  D values are 
plotted against mixing ratio, expressed as volume of dextran(-)/ volume total dextran.   
Simulation data takes into account the ratio of 5/2 positive to negative charge between 
dextran(+) and dextran(-).  Reprinted with permission from Hansing, J.; Duke, J.R.; 
Fryman, E.B.; DeRouchey, J.E.; Netz, R.R. Diffusion in polymer gels with competing 





Using FCS, the diffusion of a negatively charged probe molecule in mixed and pure 
charged dextran solutions was measured.  At mixing ratios between 0 and 0.75 negative to 
positive dextran, the diffusion of the negative probe molecule was nearly identical to 
diffusion in a purely positive dextran solution.  This is in accordance with the idea that 
biogels possessing zwitterionic charge are able to filter out particles based upon the 
magnitude of charge, not simply the sign, proposed by Leileg and others. 83, 85  Brownian 
dynamic simulations by Hansing and Netz were found to also support this idea of filtration 
based upon magnitude, and a mechanism of particle entrapment in areas of high attractive 
charge density was observed in model networks.  These simulations were found to be 
experimentally validated by the diffusion measurements carried out in mixed charge 
dextran solutions presented in this work.  Future work may focus on creation of new 
zwitterionic polymer molecules to further validate simulations.  Mixtures of CM and 
DEAE dextran are limited in that the charge density on each has not been tuned further 
than that of the manufacturer.  Additionally, it would be interesting to see if the model 
system still finds agreement in polymer systems where patches of positive and negative 
charge occur on the same polymer molecule, rather than on separate chains. In this way, 
the level of disorder of charge may be modulated in gel solutions.    
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